The
@GoogleDeepMind Science team has not pivoted; it had expanded its work. We are continuing to tackle the hardest problems in Science and Biology—from understanding protein function and deciphering the genome to enabling de-novo protein and enzyme design, while also accelerating the process of scientific discovery by developing Gemini-powered agents.
The culture of
@GoogleDeepMind is to empower our scientists. They have agency over which challenging goals they want to pursue, and this is true for the AlphaFold team as well.
Google DeepMind is pivoting from attacking hard biological problems to joining the race for an "AI scientist." This will likely harvest a lot of low-hanging fruit, but I think it will stall our actual understanding of biology.
If we think of biological knowledge and drug discovery as a distribution, we currently observe only a slice of it, along only a few dimensions. That is why drug discovery remains largely a matter of luck rather than optimisation over known parameters, and luck is not something LLMs with better reasoning can fix.
What we need is new biological data, generated specifically to expose the missing dimensions and the unobserved mass of that distribution. Above all, we need causal data and models with strong inductive biases, AlphaFold2 being the obvious example. Almost everything since has been reaping the fruit AF2 planted.
If this resonates with you and you have a strong AI background, come work with us.